Previous close | 1.3000 |
Open | 1.1700 |
Bid | 1.2100 x 300 |
Ask | 1.2400 x 200 |
Day's range | 1.1500 - 1.2400 |
52-week range | 0.8500 - 2.2400 |
Volume | |
Avg. volume | 8,441,572 |
Market cap | 860.785M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2500 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 4.25 |
Q1 2024 OPKO Health Inc Earnings Call
Key developments include a major asset sale and a focus on pharmaceutical innovation, despite a challenging financial quarter.
Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.